Hexvix fluorescence cystoscopy regulatory update

PHO submitted an MAA for Swedish approval of its Hexvix to diagnose bladder cancer. This is the first MAA for the technology. In September, PHO reported that Hexvix detected 97% of carcinoma in situ (...